These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1167 related items for PubMed ID: 12629342

  • 21. Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy.
    Simhan J, Canter DJ, Sterious SN, Smaldone MC, Tsai KJ, Li T, Viterbo R, Chen DY, Greenberg RE, Kutikov A, Uzzo RG.
    J Urol; 2013 Jan; 189(1):43-7. PubMed ID: 23164383
    [Abstract] [Full Text] [Related]

  • 22. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C, Song C, Hong JH, Kim CS, Ahn H.
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [Abstract] [Full Text] [Related]

  • 23. Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival.
    Takagi T, Kondo T, Izuka J, Kobayashi H, Tomita E, Hashimoto Y, Tanabe K.
    Int J Urol; 2011 Dec; 18(12):806-12. PubMed ID: 21917022
    [Abstract] [Full Text] [Related]

  • 24. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J, Shuch B, Riggs S, Liang LJ, Saadat A, Kabbinavar F, Pantuck A, Belldegrun A.
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [Abstract] [Full Text] [Related]

  • 25. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC, Zincke H, Lohse CM, Sebo TJ, Riehle D, Weaver AL, Blute ML.
    Cancer; 2002 Apr 15; 94(8):2180-4. PubMed ID: 12001115
    [Abstract] [Full Text] [Related]

  • 26. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
    Fujii Y, Saito K, Iimura Y, Sakai Y, Koga F, Kawakami S, Kumagai J, Kihara K.
    J Urol; 2008 Oct 15; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
    [Abstract] [Full Text] [Related]

  • 27. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma.
    Leibovich BC, Lohse CM, Crispen PL, Boorjian SA, Thompson RH, Blute ML, Cheville JC.
    J Urol; 2010 Apr 15; 183(4):1309-15. PubMed ID: 20171681
    [Abstract] [Full Text] [Related]

  • 28. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
    Carini M, Minervini A, Lapini A, Masieri L, Serni S.
    J Urol; 2006 Jun 15; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
    [Abstract] [Full Text] [Related]

  • 29. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W, Sanchez-Ortiz R, Tamboli P, Tannir N, Jonasch E, Merchant MM, Matin S, Swanson DA, Wood CG.
    J Urol; 2007 Nov 15; 178(5):1896-900. PubMed ID: 17868729
    [Abstract] [Full Text] [Related]

  • 30. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC, Blute M, Cheville JC, Lohse CM, Weaver AL, Zincke H.
    J Urol; 2004 Mar 15; 171(3):1066-70. PubMed ID: 14767272
    [Abstract] [Full Text] [Related]

  • 31. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
    Weight CJ, Kim SP, Lohse CM, Cheville JC, Thompson RH, Boorjian SA, Leibovich BC.
    Eur Urol; 2011 Sep 15; 60(3):458-64. PubMed ID: 21514718
    [Abstract] [Full Text] [Related]

  • 32. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
    Klatte T, Patard JJ, de Martino M, Bensalah K, Verhoest G, de la Taille A, Abbou CC, Allhoff EP, Carrieri G, Riggs SB, Kabbinavar FF, Belldegrun AS, Pantuck AJ.
    J Urol; 2008 May 15; 179(5):1719-26. PubMed ID: 18343437
    [Abstract] [Full Text] [Related]

  • 33. The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinoma.
    Svatek RS, Lotan Y, Herman MP, Duchene DA, Sagalowsky AI, Cadeddu JA.
    J Urol; 2006 Oct 15; 176(4 Pt 1):1321-5; discussion 125. PubMed ID: 16952621
    [Abstract] [Full Text] [Related]

  • 34. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, Weaver AL, Parker AS, Zincke H.
    Cancer; 2003 Apr 01; 97(7):1663-71. PubMed ID: 12655523
    [Abstract] [Full Text] [Related]

  • 35. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol.
    Siddiqui SA, Frank I, Cheville JC, Lohse CM, Leibovich BC, Blute ML.
    BJU Int; 2009 Sep 01; 104(6):778-85. PubMed ID: 19338559
    [Abstract] [Full Text] [Related]

  • 36. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F, Siemer S, Humke U, Hack M, Ziegler M, Stöckle M.
    Eur Urol; 2006 Feb 01; 49(2):308-13. PubMed ID: 16359779
    [Abstract] [Full Text] [Related]

  • 37. Contralateral metachronous tumor occurrence is more frequently associated with distant metastases or postoperative intrarenal recurrence in renal cell carcinoma patients.
    Amano H, Kondo T, Hashimoto Y, Kobayashi H, Iizuka J, Shimada K, Nakazawa H, Ito F, Tanabe K.
    Int J Urol; 2010 Jul 01; 17(7):615-22. PubMed ID: 20482658
    [Abstract] [Full Text] [Related]

  • 38. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
    Antonelli A, Cozzoli A, Simeone C, Zani D, Zanotelli T, Portesi E, Cosciani Cunico S.
    BJU Int; 2006 Mar 01; 97(3):505-8. PubMed ID: 16469016
    [Abstract] [Full Text] [Related]

  • 39. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF, Ribeiro-Filho LA, Antunes AA, Crippa A, Nesrallah L, Gonçalves PD, Leite KR, Srougi M.
    J Urol; 2007 Aug 01; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [Abstract] [Full Text] [Related]

  • 40. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.
    Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H.
    J Urol; 2004 Aug 01; 172(2):465-9. PubMed ID: 15247704
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.